LPTX Historical PE Ratio image   This LPTX PE ratio history page last updated 5/16/2022
LPTX Historical PE Ratio Chart
Data adjusted for LPTX split history

PeriodPriceGAAPAnnualizedPE
Q1 2022
5/13/2022
1.31-0.09-0.36NA
Q4 2021
3/11/2022
1.74-0.10-0.40NA
Q3 2021
11/12/2021
2.46-0.14-0.56NA
Q2 2021
8/13/2021
1.68-0.12-0.48NA
Q1 2021
5/14/2021
1.57-0.12-0.48NA
Q4 2020
3/12/2021
2.39-0.09-0.36NA
Q3 2020
11/12/2020
1.54-0.09-0.36NA
Q2 2020
8/13/2020
1.91-0.12-0.48NA
Q1 2020
5/14/2020
2.20-0.55-2.20NA
Q4 2019
3/16/2020
1.30-0.32-1.28NA
Q3 2019
11/14/2019
0.63-0.33-1.32NA
Q2 2019
8/9/2019
1.55-0.37-1.48NA
Q1 2019
5/15/2019
1.54-0.47-1.88NA
Q4 2018
4/1/2019
1.95-0.35-1.40NA
Q3 2018
11/9/2018
4.16-0.55-2.20NA
Q2 2018
8/8/2018
6.59-0.50-2.00NA
Q1 2018
5/11/2018
7.42-0.85-3.40NA
Q4 2017
2/23/2018
6.59-0.65-2.60NA
Q3 2017
11/13/2017
6.25-0.73-2.92NA
LPTX PE History Chart
PeriodPriceGAAPTTMPE
Q1 2022
5/13/2022
1.31-0.09-0.45NA
Q4 2021
3/11/2022
1.74-0.10-0.48NA
Q3 2021
11/12/2021
2.46-0.14-0.47NA
Q2 2021
8/13/2021
1.68-0.12-0.42NA
Q1 2021
5/14/2021
1.57-0.12-0.42NA
Q4 2020
3/12/2021
2.39-0.09-0.85NA
Q3 2020
11/12/2020
1.54-0.09-1.08NA
Q2 2020
8/13/2020
1.91-0.12-1.32NA
Q1 2020
5/14/2020
2.20-0.55-1.57NA
Q4 2019
3/16/2020
1.30-0.32-1.49NA
Q3 2019
11/14/2019
0.63-0.33-1.52NA
Q2 2019
8/9/2019
1.55-0.37-1.74NA
Q1 2019
5/15/2019
1.54-0.47-1.87NA
Q4 2018
4/1/2019
1.95-0.35-2.25NA
Q3 2018
11/9/2018
4.16-0.55-2.55NA
Q2 2018
8/8/2018
6.59-0.50-2.73NA
Q1 2018
5/11/2018
7.42-0.85NANA
Q4 2017
2/23/2018
6.59-0.65NANA
Q3 2017
11/13/2017
6.25-0.73NANA
Quotes delayed 20 minutes

Email EnvelopeFree LPTX Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Leap Therapeutics (LPTX) is categorized under the Healthcare sector; to help you further research PE history across stocks, below are some other companies in the same sector:

LQDA PE Ratio History
LRMR PE Ratio History
LTRN PE Ratio History
LUMO PE Ratio History
LUNG PE Ratio History
LXRX PE Ratio History
LYEL PE Ratio History
LYRA PE Ratio History
MACK PE Ratio History
MASI PE Ratio History
How should the LPTX historical PE ratio be determined?
Realizing that PE stands for Price to Earnings ratio, we need two values to compute it: stock price and earnings per share. The stock price at any given date is a known historical value, but what about the earnings number to use?

✔️Accepted answer: There are a number of different approaches when it comes to calculating a historical PE ratio for a company like Leap Therapeutics. We like to take our measurements on each of the past quarterly earnings reports. That only leaves the question of whether the earnings number at that quarterly report should be used on an annualized basis, or some other method. We approach this question using three different methods, on this LPTX Historical PE Ratio page.

What is the average historical PE for LPTX based on annualized quarterly earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use that quarter's earnings result annualized?

✔️Accepted answer: The LPTX historical PE ratio using the annualized quarterly earnings method works out to NA.

What is the average historical PE for LPTX based on trailing twelve month earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use the trailing twelve months combined earnings result in the calculation?

✔️Accepted answer: The LPTX historical PE ratio using the TTM earnings method works out to NA.

On this page we presented the LPTX Historical PE Ratio information for Leap Therapeutics' stock. The average LPTX historical PE based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is NA. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average LPTX historical PE based on this TTM earnings result method is NA. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this LPTX historical PE result, against the recent PE: when this page was posted on 5/13/2022, the most recent closing price for LPTX had been 1.31, and the most recent quarterly earnings result, annualized, was NA. Meanwhile, the most recent TTM earnings summed to NA.

For self directed investors doing their due diligence on LPTX or any other given stock, valuation analysis for LPTX can greatly benefit from studying the past earnings and resulting PE calculations. This exercise can help inform an analysis as to whether the past earnings trajectory and current versus historical PE ratios justify the current stock value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate Leap Therapeutics PE history or the past PE information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for LPTX. Thanks for visiting, and the next time you need to research LPTX Historical PE Ratio or the ratio for another stock, we hope you'll think of our site, as your go-to historical PE ratio research resource of choice.

Recommended: Institutional Holders of TYO, GD Next Dividend Date, EMGC Insider Buying.

 

LPTX Historical PE Ratio | www.HistoricalPERatio.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in HistoricalPERatio.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.